28 results
8-K
EX-99.1
TTOO
T2 Biosystems Inc
28 Mar 24
Regulation FD Disclosure
4:31pm
, today announced that its multi-year capital equipment supplier agreement with Vizient, Inc., the largest member-driven health care performance … directly from blood.
Vizient serves a wide range of health care organizations that represent a combined purchasing volume of approximately $100 billion
8-K
EX-10.1
TTOO
T2 Biosystems Inc
15 Feb 24
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
4:47pm
compliance with applicable health care laws (collectively, “Health Care Laws”). Neither the Company nor any of its subsidiaries has received notice … or third party alleging that any product operation or activity is in material violation of any Health Care Laws or Authorizations and has no knowledge
8-K
EX-99.1
TTOO
T2 Biosystems Inc
17 Oct 23
Results of Operations and Financial Condition
4:31pm
to have a crude ICU mortality rate of 34% to 43%. Acinetobacter infections rarely occur outside of health care settings in the United States and can
8-K
EX-99.2
TTOO
T2 Biosystems Inc
11 Aug 23
T2 Biosystems Announces Second Quarter 2023 Financial Results
4:00pm
rate of 34% to 43%. Acinetobacter infections rarely occur outside of health care settings in the United States and can disproportionately impact those
8-K
EX-10.2
95vqv6
6 Jul 23
Entry into a Material Definitive Agreement
8:08am
8-K
EX-99.2
d60gtpp6la8xju0dw73p
25 May 23
T2 Biosystems Announces First Quarter 2023 Financial Results
4:55pm
8-K
EX-99.2
wbo36tilrhpy6o xtk4s
17 Feb 22
T2 Biosystems Announces Fourth Quarter & Full Year 2021 Financial Results
5:30pm
8-K
EX-99.2
n5cjb1fgo
25 Mar 20
T2 Biosystems Announces Preliminary First Quarter 2020 Financial Results
12:00am
8-K
EX-99.2
i33pi3 emw4uo
13 Nov 19
T2 Biosystems Reports Third Quarter 2019 Financial Highlights and Provides Corporate Update
3:19pm
8-K
EX-99.2
jt9v qeqdugnbs494y
13 Mar 19
T2 Biosystems Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
10:00am
8-K
EX-99.2
u1swd23 nre
6 Nov 18
T2 Biosystems Reports Third Quarter 2018 Financial Results and Provides Corporate Update
12:55pm